DUBLIN, Jan. 17, 2024 /PRNewswire/ — The “Robot-assisted Endoscope Market Size, Share & Trends Analysis Report By End-use (Hospitals, Outpatient Facilities), By Region (North America, Asia Pacific, Europe, Latin America, MEA), And Segment Forecasts, 2023 – 2030” report has been added to ResearchAndMarkets.com’s offering.
The global robot-assisted endoscope market size is expected to reach USD 2.36 billion by 2030, registering a CAGR of 8.2% from 2023 to 2030. Age-related medical disorders requiring endoscopic operations are more prevalent as a result of the world’s aging population. Endoscopes with robotic assistance assist in overcoming the difficulties of complex procedures on elderly people. Due to their advantages, such as less trauma, shorter hospital stays, and quicker recovery times, minimally invasive surgical methods have become increasingly popular. Surgeons can carry out intricate treatments with more precision and through smaller incisions with the help of robot-assisted endoscopes.
Factors, such as the demand for minimally invasive surgical (MIS) treatments, new product approvals by regulatory bodies like the U.S. FDA, and the prevalence of chronic illnesses are boosting the market growth. Moreover, the increasing collaboration activities among key players for the development of laparoscopy instruments drive market growth. For instance, in February 2021, Asensus Surgical Inc. and the Amsterdam Skills Centre, Netherlands partnered to create a second European Surgical Training Site for Senhance Digital Laparoscopy. The use of this robotic system in general surgery, including endoscopic operations, is recommended. Thus, it is anticipated that the market in this region will rise at a faster rate during the projected period as a result of the rising prevalence of bowel disorders, the growing elderly population, and the presence of major players with ongoing product advancements.
To prioritize COVID-19 patients and lower the danger of transmission during the pandemic, several healthcare facilities put off elective operations. The lack of urgent endoscopic treatments temporarily decreased the demand for robot-assisted endoscopes. To shorten hospital stays and lower the danger of infection, there was a growing emphasis on adopting minimally invasive surgical methods. As robot-assisted endoscopes provide advantages in terms of smaller incisions and quicker recovery times, this shift in desire may have had a favorable impact on their uptake. The COVID-19 pandemic raised attention to the value of cutting-edge medical technologies and sped up research and development initiatives within the healthcare sector. System improvements for robot-assisted endoscopy may have resulted from this greater emphasis on innovation and technology.
In addition, the market growth is driven by an increase in the number of mergers & acquisitions in the healthcare sector as well as significant investments for its improvement. In May 2022, Creo Medical Group, a significant manufacturer of medical devices, signed a long-term partnership agreement with Intuitive, a leader in robotic surgery and a global pioneer in less-invasive care, to promote compatibility among Creo surgery technology and therapeutic robotic systems. Patients will have more state-of-the-art treatment options due to the combination of Creo’s Kamaptive technology and Intuitive’s robotic platform. On the other hand, the market growth is likely to be hampered by the high cost of endoscopic treatments and a shortage of qualified personnel. The market will be challenged by a scarcity of qualified workers and a lack of healthcare facilities in developing nations.
Robot-assisted Endoscope Market Report Highlights
Based on the end-use, the outpatient facilities segment dominated the market with a market share of 53.31% in 2022
Robotic systems are employed to perform endoscopic treatments with more accuracy and dexterity, improving patient outcomes and diagnostic precision
North America dominated the global market with a revenue share of 41.81% of the revenue share in 2022
Both the United States and Canada have established regulatory frameworks for medical devices, including robot-assisted endoscopes, which have facilitated their entry into the market
The FDA clearance of the robotic endoscopy devices creates a positive impact on enhancing the product portfolio for the industry’s key players
For instance, in March 2021, the Senhance Surgical System was approved by the FDA in the U.S., according to a statement from Asensus Surgical Inc. It was advised to use this robotic system for endoscopy and other general surgery procedures
Key Topics Covered:
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increasing incidence of chronic disease
3.2.1.2. Technological advancements of robot-assisted endoscopes
3.2.2. Market Restraint Analysis
3.2.2.1. High cost of endoscopic systems
3.3. Industry Analysis Tools
Chapter 4. End-use Business Analysis
4.1. Robot-Assisted Endoscopes Market: End-use Movement Analysis
4.2. Hospitals
4.3. Outpatient Facilities
Chapter 5. Regional Business Analysis
5.1. Robot-Assisted Endoscopes Market Share By Region, 2022 & 2030
5.2. North America
5.3. Europe
5.4. Asia Pacific
5.5. Latin America
5.6. MEA
Chapter 6. Competitive Landscape
Asensus Surgical US
Intuitive Surgical
Auris Health
Johnson & Johnson Services
Brainlab
Medtronic
Boston Scientific
Stryker
For more information about this report visit https://www.researchandmarkets.com/r/gltw3q
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
SOURCE Research and Markets